Themes

Century secures $60m in stock sale and buys preclinical cell therapy biotech

Century will pay $35m upfront and an additional $10m milestone payments to acquire Clade Therapeutics.

Artificial Intelligence

View More

Cloud

View More

Corporate Governance

View More

Cybersecurity

View More

Environmental Sustainability

View More

Internet of Things

View More

Robotics

View More

Social Responsibility

View More
close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close